Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT+ procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG)

被引：19
|
作者：
Shaw, E. G.
Wang, M.
Coons, S.
Brachman, D.
Buckner, J. C.
Stelzer, K.
Barger, G.
Brown, P. D.
Gilbert, M. R.
Mehta, M. P.
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Barrow Neurol Inst, Phoenix, AZ 85013 USA
[4] Arizona Oncol Serv Fdn, Phoenix, AZ USA
[5] Mayo Clin, Rochester, MN USA
[6] Celilo Canc Ctr, The Dalles, WA USA
[7] Wayne State Univ, Sch Med, Detroit, MI USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Univ Wisconsin, Sch Med, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.2006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2006
引用
收藏
页数：1
相关论文
共 30 条
  • [21] The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria
    Andrea Lanese
    Enrico Franceschi
    Alba A. Brandes
    Oncology and Therapy, 2018, 6 (2) : 105 - 108
  • [22] The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria
    Lanese, Andrea
    Franceschi, Enrico
    Brandes, Alba A.
    ONCOLOGY AND THERAPY, 2018, 6 (02) : 105 - 108
  • [23] Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group protocol 88-06
    Schultz, C
    Scott, C
    Sherman, W
    Donahue, B
    Fields, J
    Murray, K
    Fisher, B
    Abrams, R
    MeisKindblom, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 556 - 564
  • [24] Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase 2 Study ACNS0221
    Cherlow, Joel M.
    Shaw, Dennis W. W.
    Margraf, Linda R.
    Bowers, Daniel C.
    Huang, Jie
    Fouladi, Maryam
    Onar-Thomas, Arzu
    Zhou, Tianni
    Pollack, Ian F.
    Gajjar, Amar
    Kessel, Sandy K.
    Cullen, Patricia L.
    McMullen, Kevin
    Wellons, John C.
    Merchant, Thomas E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (04): : 861 - 868
  • [25] A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RI followed by chemotherapy with paclitaxel, estramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902
    Sandler, H. M.
    Hunt, D.
    Sartor, A. O.
    Gomella, L. G.
    Hartford, A.
    Zeitzer, K. L.
    Rajan, R.
    Kerlin, K.
    Michalski, J. M.
    Rosenthal, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12
    Komaki, R
    Swann, RS
    Ettinger, DS
    Glisson, BS
    Sandler, AB
    Movsas, B
    Suh, J
    Byhardt, RW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (02): : 342 - 350
  • [27] Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma
    Breen, William G.
    Anderson, S. Keith
    Carrero, Xiomara W.
    Brown, Paul D.
    Ballman, Karla, V
    O'Neill, Brian P.
    Curran, Walter J.
    Abrams, Ross A.
    Laack, Nadia N.
    Levitt, Ralph
    Galanis, Evanthia
    Buckner, Jan C.
    Shaw, Edward G.
    NEURO-ONCOLOGY, 2020, 22 (06) : 830 - 837
  • [28] LONG-TERM OUTCOMES FROM INTERGROUP NCCTG 86-72-51 (ALLIANCE): FINAL REPORT OF A PHASE III PROSPECTIVE RANDOMIZED TRIAL OF HIGH DOSE VERSUS LOW DOSE RADIATION IN ADULT SUPRATENTORIAL LOW-GRADE GLIOMA
    Breen, William
    Anderson, S. Keith
    Carrero, Xiomara
    Brown, Paul
    Ballman, Karla
    O'Neill, Brian
    Curran, Walter
    Abrams, Ross
    Laack, Nadia
    Levitt, Ralph
    Galanis, Evanthia
    Buckner, Jan
    Shaw, Edward
    NEURO-ONCOLOGY, 2019, 21 : 13 - 14
  • [29] Dactinomycin (A) and vincristine (V) with or without cyclophosphamide (C) and radiation therapy (RT) for newly diagnosed patients with low-risk embryonal/botryoid rhabdomyosarcoma (RMS). An IRS-V report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (STS COG).
    Walterhouse, D. O.
    Meza, J. L.
    Raney, R. B.
    Anderson, J.
    Wiener, E. S.
    Donaldson, S. S.
    Qualman, S. J.
    Meyer, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 502S - 502S
  • [30] Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group
    Raney, R. Beverly
    Walterhouse, David O.
    Meza, Jane L.
    Andrassy, Richard J.
    Breneman, John C.
    Crist, William M.
    Maurer, Harold M.
    Meyer, William H.
    Parham, David M.
    Anderson, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) : 1312 - 1318
123